Tags: Drug.

Bazedoxifene is a third generation selective estrogen receptor modulator (SERM) developed by Pfizer following the completion of their takeover of Wyeth Pharmaceuticals. In late 2013 Pfizer received approval for bazedoxifene as part of the combination drug DUAVEE in the prevention (not treatment) of postmenopausal osteoporosis. Bazedoxfiene is the result of an exclusive research collaboration between Wyeth Pharmaceuticals and Ligand Pharmaceuticals.

Bazedoxifene.svg
ATC prefix
G03
ATC suffix
XC02
CAS number
198481-32-2
FDA UNII code
Q16TT9C5BK
IUPAC name
1-4-[2-(Azepan-1-yl)ethoxy]benzyl-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol
PubChem
154257

Loading...

This page contains content from the copyrighted Wikipedia article "Bazedoxifene"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.